Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs. Prasugrel in Stable Chronic Coronary Artery Disease
NCT05247385Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor, prasugrel in coronary artery disease (CAD), sponsored by Universidade de São Paulo. Started Mar 2017; status: completed.
02
Drugs
ticagrelorprasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05247385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247385.